CF Alliance Successfully Organized the Third Sino-RoK High-tech Investment Projects Roadshow

On September 27, hosted by the South Korean KITIA Association, China International Technology Transfer Center and organized by the Beijing Changfeng Information Technology Industry Alliance, and Zetaplan Investment Company, the Third Sino-RoK High-tech Investment Projects Roadshow was successfully held in Beijing.
The South Korean KITIA Association brought 17 companies to attend the projects road show, with nearly twenty technology projects covering the sectors of ICT, medical equipment, biological medicine and semiconductors. The promoting projects include: biological age analysis service system; health effects processing SW-MEDIP and customized model of human organs, anti-Parkinson's disease, multiple atrophy, Parkinson's syndrome, cognitive functioning improvement therapeutic agent, molecules in cells  transmission technology(MITT), 300 mm Wafer Carrier (FOSB, foups, O/C) semiconductor mobile box; peptide or reducing peptide manufacturing cost and production process; absorbed coronary stent, disposable nano coating plastic biosensor used for disease diagnosis, disposable wearable insulin pump with low cost, and Bignote electronic blackboard technology, etc.
HuangPing, director of China International Technology Transfer Center and LEE BOOHO, manager of Korea KITIA Association presented and delivered a speech. The conference attracted numerous participants from famous enterprises including COFCO, Baidu, CIji network and Goodwill,   Sugon Information Industry Co., Ltd, and Beijing Dynamic Power. And there were nearly a hundred representatives from VC, PE and industrial parks including Chinese International Economic Cooperation and Investment Companies, CFLD, China Life Investment Holding Company Limited, Legend Capital, CSC Group, and Rongtong Science & Technology Industry Group. 
 Through the organizers’ great effort of previous matchmaking work, many companies have reached preliminary cooperation intentions including CFLD and South Korea 3 Scompany, Beijing ACCB Biotech Ltd. and APT SCI company ,  Beijing Datsing Bio-tech Co., Ltd. and SUNTECH Co., Ltd., South Korea; HuaXiPHARM Group and MEDIHELP LINE.
This activity aims to promote the Korean advanced and innovative technology in such sectors as IT, medical equipments and  biological medicine etc. and further promote China and South Korea enterprise cooperation in technology transfer, licensing, R&D, joint venture and investment and M&A, etc.

Previous page:Sino-France Innovations & Start-ups Senimar held successfully

Next page:droidcon Founder meets CF Alliance to finalise plans for droidcon Beijing 2016
Navigation ∨